Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection
Study Identifier
P12-760
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
N/A
Protocol Summary
This study of Kaletra (Lopinavir (LPV)/Ritonavir (RTV)) tablets will be conducted to clarify the following with regard to treatment with this drug:
1. Incidence and conditions of occurrence of adverse reactions in the clinical setting
2. Factors that may affect the safety and effectiveness of Kaletra (QD)
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 57629
Fukuoka, Japan
Status
Not applicable
Location
Site Reference ID/Investigator# 57630
Hiroshima, Japan
Status
Not applicable
Location
Site Reference ID/Investigator# 57631
Hokkaido, Japan
Status
Not applicable
Location
Site Reference ID/Investigator# 57628
Kitakyushu-shi, Japan
Status
Not applicable
Location
Site Reference ID/Investigator# 57638
Kurashiki-shi, Japan
Status
Not applicable
Location
Site Reference ID/Investigator# 57634
Kyoto, Japan
Status
Not applicable
Showing {first} - {last} of {total} Results